Strengthening Healthcare Systems to Meet Patients’ Need for Plasma-Derived Therapies

The Need for Plasma-Derived Therapies in Healthcare

October 03, 2022 : As part of their well-established collaboration, the United Nations Institute for Training and Research (UNITAR) and Takeda (TSE:4502/NYSE: TAK), an international pharmaceutical leader and a current member of the United Nations Global Compact, are delighted to announce a new joint initiative concentrated on strengthening countries’ healthcare systems to satisfy patients’ need for plasma and plasma-derived therapies.